ヒアルロン酸(HA)原材料の世界市場分析:用途別(眼科、整形外科、皮膚科、薬品送達、医療機器コーティング、バイオマテリアル・インプラント、組織保存)、セグメント予測、2013 – 2024...市場調査レポートについてご紹介

【英文タイトル】Hyaluronic Acid (HA) Raw Material Market Analysis By Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Devices Coating, Biomaterials & Implants, Tissue Preservation), And Segment Forecasts, 2013 - 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Primary Research:
1.2.1 List of primary sources include
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Hyaluronic acid raw material Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Demographic shift in the U.S.
3.1.1.2 Growing demand for anti-aging solutions and minimally invasive aesthetic treatments
3.1.1.3 Growing usage of hyaluronic acid in cosmetic and medical field
3.1.2 Market restraint analysis
3.1.2.1 High costs and side effects associated with the use of hyaluronic acid
3.2 Key Opportunity Priorities
3.3 Hyaluronic Acid – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Hyaluronic acid raw material: Application Estimates & Trend Analysis
4.1 Hyaluronic Acid Market: Application Movement Analysis
4.2 Ophthalmology
4.2.1 Ophthalmology market revenue, 2013 – 2024 (USD Million)
4.2.2 Ophthalmology market volume, 2013 – 2024 (Thousand Kilograms)
4.2.3 Cataract surgery
4.2.3.1 Cataract surgery market revenue, 2013 – 2024 (USD Million)
4.2.3.2 Cataract surgery market volume, 2013 – 2024 (Thousand Kilograms)
4.2.4 Aqueous eye drop
4.2.4.1 Aqueous eye drop market revenue, 2013 – 2024 (USD Million)
4.2.4.2 Aqueous eye drop market volume, 2013 – 2024 (Thousand Kilograms)
4.2.5 Contact lens
4.2.5.1 Contact lens market revenue, 2013 – 2024 (USD Million)
4.2.5.2 Contact lens market volume, 2013 – 2024 (Thousand Kilograms)
4.3 Orthopedics
4.3.1 Orthopaedics market revenue, 2013 – 2024 (USD Million)
4.3.2 Orthopedics market volume, 2013 – 2024 (Thousand Kilograms)
4.3.3 Viscosupplements
4.3.3.1 Viscosupplements market revenue, 2013 – 2024 (USD Million)
4.3.3.2 Viscosupplements market volume, 2013 – 2024 (Thousand Kilograms)
4.3.4 Bone regeneration
4.3.4.1 Bone regeneration market revenue, 2013 – 2024 (USD Million)
4.3.4.2 Bone regeneration market volume, 2013 – 2024 (Thousand Kilograms)
4.4 Dermatology
4.4.1 Dermatology market revenue, 2013 – 2024 (USD Million)
4.4.2 Dermatology market volume, 2013 – 2024 (Thousand Kilograms)
4.4.3 Intradermal injections
4.4.3.1 Intradermal market revenue, 2013 – 2024 (USD Million)
4.4.3.2 Intradermal market volume, 2013 – 2024 (Thousand Kilograms)
4.4.4 Dermal fillers
4.4.4.1 Dermal fillers market revenue, 2013 – 2024 (USD Million)
4.4.4.2 Dermal filler market volume, 2013 – 2024 (Thousand Kilograms)
4.4.5 Wound healing
4.4.5.1 Wound healing market revenue, 2013 – 2024 (USD Million)
4.4.5.2 Wound healing market volume, 2013 – 2024 (Thousand Kilograms)
4.5 Drug Delivery
4.5.1 Drug delivery market revenue, 2013 – 2024 (USD Million)
4.5.2 Drug delivery market volume, 2013 – 2024 (Thousand Kilograms)
4.6 Medical Device Coating
4.6.1 Medical device coating market revenue, 2013 – 2024 (USD Million)
4.6.2 Medical device coating market volume, 2013 – 2024 (Thousand Kilograms)
4.7 Surgical Adhesion Prevention
4.7.1 Surgical adhesion prevention market revenue, 2013 – 2024 (USD Million)
4.7.2 Surgical adhesion prevention market volume, 2013 – 2024 (Thousand Kilograms)
4.8 Biomaterials and Implants
4.8.1 Biomaterial and implant market revenue, 2013 – 2024 (USD Million)
4.8.2 Biomaterial and implant market volume, 2013 – 2024 (Thousand Kilograms)
4.9 Cell and Tissue Preservation
4.9.1 Cell and tissue preservation market revenue, 2013 – 2024 (USD Million)
4.9.2 Cell and tissue preservation market volume, 2013 – 2024 (Thousand Kilograms)
Chapter 5 Hyaluronic acid raw material: Regional Estimates & Trend Analysis, by Application
5.1 Hyaluronic Acid Market Share, by Region, 2015 & 2024
5.2 North America
5.2.1 North America hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.2.2 North America hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.2.3 U.S
5.2.3.1 U.S. hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.2.3.2 U.S. hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.2.4 Canada
5.2.4.1 Canada hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.2.4.2 Canada hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.3 Europe
5.3.1 Europe hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.3.2 Europe hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.3.3 UK
5.3.3.1 UK hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.3.3.2 UK hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.3.4 Germany
5.3.4.1 Germany hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.3.4.2 Germany hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.4 Asia Pacific
5.4.1 Asia Pacific hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.4.2 Asia Pacific hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.4.3 Japan
5.4.3.1 Japan hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.4.3.2 Japan hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.4.4 China
5.4.4.1 China hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.4.4.2 China hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.5 Latin America
5.5.1 Latin America hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.5.2 Latin America hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.5.3 Brazil
5.5.3.1 Brazil hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.5.3.2 Brazil hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.5.4 Mexico
5.5.4.1 Mexico hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.5.4.2 Mexico hyaluronic acid market, 2013 – 2024 (Thousand Kilograms)
5.6 MEA
5.6.1 MEA hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.6.2 MEA hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
5.6.3 South Africa
5.6.3.1 South Africa hyaluronic acid market revenue, by application 2013 – 2024 (USD Million)
5.6.3.2 South Africa hyaluronic acid market volume, by application 2013 – 2024 (Thousand Kilograms)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 Allergan
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 Sanofi
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic initiatives
6.1.3 Genzyme Corporation
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 Anika Therapeutics, Inc.
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic initiatives
6.1.5 Salix Pharmaceuticals
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Product benchmarking
6.1.5.4 Strategic initiatives
6.1.6 Seikagaku Corporation
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.3 Product benchmarking
6.1.7 F. Hoffmann-La Roche Ltd.
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic initiatives
6.1.8 Galderma S.A.
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic initiatives
6.1.9 Zimmer Biomet
6.1.9.1 Company overview
6.1.9.2 Financial performance
6.1.9.3 Product benchmarking
6.1.10 Smith & Nephew
6.1.10.1 Company overview
6.1.10.2 Financial performance
6.1.10.3 Product benchmarking
6.1.10.4 Strategic initiatives
Chapter 7 Raw Material Suppliers Competitive Landscape
7.1 Company Profiles
7.1.1 Lifecore Biomedical
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic Initiatives
7.1.2 HTL Biotechnology
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.3 Shiseido
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 Bloomage Freda Biopharm Co. Ltd.
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 LG Life Sciences
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Maruha Nichiro, Inc.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 Contipro
7.1.7.1 Company Overview
7.1.7.2 Financial Performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic Initiatives
7.1.8 Bio-Technology General
7.1.8.1 Company Overview
7.1.8.2 Financial Performance
7.1.8.3 Product Benchmarking
7.1.9 Teoxane Laboratories
7.1.9.1 Company Overview
7.1.9.2 Financial Performance
7.1.9.3 Product Benchmarking
7.1.9.4 Strategic Initiatives
7.1.10 QufuLiyangBiochem Industrial Co. Ltd
7.1.10.1 Company Overview
7.1.10.2 Financial Performance
7.1.10.3 Product Benchmarking
7.1.11 Cellbone Technology
7.1.11.1 Company Overview
7.1.11.2 Financial Performance
7.1.11.3 Product Benchmarking
7.1.12 Stanford Chemicals
7.1.12.1 Company Overview
7.1.12.2 Financial Performance
7.1.12.3 Product Benchmarking
7.1.13 Vesta Ingredients, Inc.
7.1.13.1 Company Overview
7.1.13.2 Financial Performance
7.1.13.3 Product Benchmarking
7.2 Hyaluronic Acid Raw Material Manufactures’ Market Share, 2015


【レポート販売概要】

■ タイトル:ヒアルロン酸(HA)原材料の世界市場分析:用途別(眼科、整形外科、皮膚科、薬品送達、医療機器コーティング、バイオマテリアル・インプラント、組織保存)、セグメント予測、2013 – 2024
■ 英文:Hyaluronic Acid (HA) Raw Material Market Analysis By Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Devices Coating, Biomaterials & Implants, Tissue Preservation), And Segment Forecasts, 2013 - 2024
■ 発行日:2017年3月29日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707411
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。